Cargando…
Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone
At present, prostate-specific antigen (PSA) is used as a clinical biomarker for prostate cancer (PCa) diagnosis; however, a large number of patients with benign prostate hyperplasia (BPH) with PSA levels in the ʻgray areaʼ (4–10 ng/ml) are currently subjected to unnecessary biopsy due to overdiagnos...
Autores principales: | SALIDO-GUADARRAMA, ALBERTO IVAN, MORALES-MONTOR, JORGE GUSTAVO, RANGEL-ESCAREÑO, CLAUDIA, LANGLEY, ELIZABETH, PERALTA-ZARAGOZA, OSCAR, COLIN, JOSE LUIS CRUZ, RODRIGUEZ-DORANTES, MAURICIO |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878542/ https://www.ncbi.nlm.nih.gov/pubmed/27081843 http://dx.doi.org/10.3892/mmr.2016.5095 |
Ejemplares similares
-
MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer
por: Salido-Guadarrama, Iván, et al.
Publicado: (2014) -
Significance of the prostate central gland and total gland volume ratio in the diagnosis of prostate cancer patients in the prostate specific antigen grey zone
por: Guo, Zhui-Feng, et al.
Publicado: (2021) -
GABA promotes gastrin-releasing peptide secretion in NE/NE-like cells: Contribution to prostate cancer progression
por: Solorzano, Susana R., et al.
Publicado: (2018) -
SFRP1 induces a stem cell phenotype in prostate cancer cells
por: Losada-García, Alberto, et al.
Publicado: (2023) -
The impact of grey zones on the accuracy of agreement measures for ordinal tables
por: Tran, Quoc Duyet, et al.
Publicado: (2021)